NCT00410189View on ClinicalTrials.gov

BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Lung Cancer
Interventions
DRUG

ZD6474

300 mg by mouth daily for 28 Days.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

AstraZeneca

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER